Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Scott Kinlay, Ph.D., M.B.,B.S.

Concepts

This page shows the publications Scott Kinlay has written about Australia.
Connection Strength

0.206
  1. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Med J Aust. 2005 Jun 06; 182(11):597-8; author reply 598.
    View in: PubMed
    Score: 0.059
  2. Cost-effectiveness of coronary angioplasty versus medical treatment: the impact of cost-shifting. Aust N Z J Med. 1996 Feb; 26(1):20-6.
    View in: PubMed
    Score: 0.031
  3. A new method of estimating cost effectiveness of cholesterol reduction therapy for prevention of heart disease. Pharmacoeconomics. 1994 Mar; 5(3):238-48.
    View in: PubMed
    Score: 0.027
  4. Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J Am Heart Assoc. 2013 Jan 28; 2(1):e003103.
    View in: PubMed
    Score: 0.025
  5. The validity of estimating heart disease reduction from a Framingham logistic equation. J Clin Epidemiol. 1992 May; 45(5):553-60.
    View in: PubMed
    Score: 0.024
  6. High cholesterol levels: is mass screening the best option? Med J Aust. 1988 Jun 20; 148(12):635-7.
    View in: PubMed
    Score: 0.018
  7. Preventive medicine in undergraduate medical education. Med J Aust. 1987 Apr 20; 146(8):425-7, 430.
    View in: PubMed
    Score: 0.017
  8. Outcome of very low birthweight infants who required prolonged hospitalization. Aust Paediatr J. 1984 Nov; 20(4):293-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.